You-Sung Suh

You-Sung Suh

Auto-generated profile, based on publicly available information

You-Sung Suh

Department of Orthopaedic Surgery, Soonchunhyang University Hospital Seoul, Seoul, Korea

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
YSYou-Sung Suh
You-Sung Suh
SWSung Hun Won
Sung Hun Won
HCHyung-Suk Choi
Hyung-Suk Choi
JLJae Chul Lee
Jae Chul Lee
DCDong-Il Chun
Dong-Il Chun
JKJin Hyeung Kim
Jin Hyeung Kim
Suh YS, et al. J Korean Med Sci. 2017 Dec;32(12):2035-2041. https://doi.org/10.3346/jkms.2017.32.12.2035

1 January 2023 in Clinics in Orthopedic Surgery
Verified
Journal Article
Open access
PDF file
BJByung-Woong Jang
Byung-Woong Jang
JKJin-Woo Kim
Jin-Woo Kim
JNJae-Hwi Nho
Jae-Hwi Nho
YLYoung-kyun Lee
Young-kyun Lee
JPJung-Wee Park
Jung-Wee Park
YSYou-Sung Suh
You-Sung Suh
Jang BW, et al. Clin Orthop Surg. 2023 Oct;15:e76. https://doi.org/10.4055/cios23223

YSYou-Sung Suh
You-Sung Suh
HCHyung-Suk Choi
Hyung-Suk Choi
JLJeong Seok Lee
Jeong Seok Lee
BJByung-Woong Jang
Byung-Woong Jang
JHJinyeong Hwang
Jinyeong Hwang
JNJae-Hwi Nho
Jae-Hwi Nho
Knee arthroplasties are strongly associated with blood transfusion to compensate for perioperative bleeding. The purpose of this study was to evaluate trends of transfusion associated with knee arthroplasties using nationwide data of the National Health Insurance Service-National Sample Cohort (NHIS-NSC). Using data from the nationwide claims database of the Health Insurance Review Assessment Service managed by the NHIS, 50,553 knee arthroplasties under three categories (total knee replacement arthroplasty, uni-knee replacement arthroplasty, and revision arthroplasty) from 2012 to 2018 were identified. Overall transfusion rate, transfusion count, proportion of each type of transfusion, and cost associated with each type of operation were investigated. Overall transfusion rate was 83.4% (5897/7066) in 2012, 82.7% (5793/7001) in 2013, 79.6% (5557/6978) in 2014, 75.9% (5742/7557) in 2015, 73.1% (6095/8337) in 2016, 68.2% (4187/6139) in 2017, and 64.6% (4271/6613) in 2018. The proportion of each type of transfusion was 1.8% for fresh frozen plasma, 0.5% for platelets, and 97.7% for red blood cells. The average cost of transfusion was $109.1 ($123 in 2012, $124 in 2013, $123.3 in 2014, $110.6 in 2015, $100 in 2016, $92.9 in 2017, and $90.1 in 2018). In this nationally representative study of trends in transfusion associated with knee arthroplasty, we observed significantly high rates of blood transfusion among patients undergoing knee arthroplasties. Although the overall rate of transfusion had declined, the allogeneic transfusion rate was still high from 2012 to 2018 in Korea. Thus, surgeons need to develop various patient blood management plans and minimize the use of allogeneic transfusion when performing knee arthroplasties.

14 November 2020 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
CPChan Ho Park
Chan Ho Park
JYJun-Il Yoo
Jun-Il Yoo
CCChang Hyun Choi
Chang Hyun Choi
YSYou-Sung Suh
You-Sung Suh
Background: Sequential therapy from bone-forming medication to resorptive agents is reportedly effective for patients with severe osteoporosis. The objective of this study is to determine the impact of implementing short-term teriparatide (TPTD) intervention before denosumab (DMab) therapy compared with DMab therapy alone for 1 year after hip fracture. Methods: We retrospectively reviewed the medical records and radiographs of patients who were treated due to osteoporotic hip fracture. TPTD was administered to 22 patients for an average of 12.1 weeks after which the intervention was switched to DMab therapy for 12 months (group 1). DMab alone was administered to 16 patients for 12 months (group 2). Bone mineral density (BMD) was evaluated before and after treatment at the 1-year follow-up. The improvement of BMD in hip and spine was compared with the levels of bone turnover marker. Results: The difference in femoral neck BMD was 0.005 ± 0.04 in group 1 and − 0.014 ± 0.10 in group 2 (p = 0.442). The difference of spine BMD was 0.043 ± 0.05 in group 1 and 0.052 ± 0.06 in group 2 (p = 0.640). BMD of the spine improved significantly in groups 1 and 2 (p < 0.001, p = 0.002). There was no statistical difference in C-terminal telopeptide and osteocalcin level. Conclusion: Short-term TPTD administration followed by DMab alone was effective only in improving spine BMD. Short-term treatment with TPTD caused mild improvement in femur neck BMD compared with DMab alone. However, further research with a longer duration of TPTD treatment is warranted, as our findings lack statistical significance.

1 January 2023 in Clinics in Orthopedic Surgery
Verified
Journal Article
Open access
PDF file
YSYou-Sung Suh
You-Sung Suh
JNJae-Hwi Nho
Jae-Hwi Nho
MSMin Gon Song
Min Gon Song
DLDongWoo Lee
DongWoo Lee
BJByung-Woong Jang
Byung-Woong Jang
Suh YS, et al. Clin Orthop Surg. 2023 Jan;15:e7. https://doi.org/10.4055/cios22149

2 January 2026 in Annals of Medicine
Verified
Journal Article
Open access
JRJae Kyong Rho
Jae Kyong Rho
SKSeong Soon Kwon
Seong Soon Kwon
BJByung-Woong Jang
Byung-Woong Jang
YSYou-Sung Suh
You-Sung Suh
SJSung Woo Jang
Sung Woo Jang
HLHaekyung Lee
Haekyung Lee
Hip fractures and acute kidney injury (AKI) are common among older adults and are each associated with increased morbidity and mortality. We aimed to evaluate whether AKI severity is associated with increased mortality and institutionalization in older adult patients with hip fractures. This single-centre, retrospective study included patients aged ≥65 years who underwent surgery for hip fractures. Those with stage 4 or 5 chronic kidney disease or end-stage kidney disease were excluded. AKI was defined and categorized according to the Kidney Disease: Improving Global Outcomes guideline. Patients who did not develop AKI served as the reference group for subsequent analyses. Overall, 661 older adults with hip fractures were included (median age: 82.0 [76.0-86.0] years, women: 76.3%). Among these, 35.9% had AKI, with 80.2, 11.8, and 8.0% classified as stages 1, 2, and 3, respectively. Thirteen patients died during hospitalization. During a median follow-up period of 4.3 (2.6-5.9) years, 301 patients died. Stage 3 AKI was associated with in-hospital mortality compared to patients without AKI (HR, 7.82 [1.21-50.72], p = 0.031). Higher AKI stages were associated with increased long-term mortality in multivariable analyses (HR, 1.32 [0.97-1.80], p = 0.076 for stage 1, HR, 2.52 [1.52-4.20], p < 0.001 for stage 2 and HR, 3.15 [1.76-5.63], p < 0.001 for stage 3). Age, men, cardiovascular disease, and low albumin level were associated with long-term mortality in patients with AKI. The proportion of institutionalization did not differ among patients across the AKI stages. Higher AKI stages are associated with increased in-hospital and long-term mortality in older adults with hip fractures. Preventing AKI development and progression is essential to improve prognosis in this vulnerable population.